Antiplatelet Drug-related Clinical Features Of Upper Gastrointestinal Bleeding

Objective Research antiplatelet drug-related clinical features of upper gastrointestinalbleeding.Methods Research Ningxia Medical University General Hospital nearly six years ofnon-variceal upper gastrointestinal bleeding in hospitalized patients clinical data, according towhether the use of anti-platelet drugs before the bleeding, divided into two groups tocompare.Results1226cases of non-variceal upper gastrointestinal bleeding in patients takinganti-platelet drugs in223cases. Group, patient gender, drinking history, history of ulcerbleeding, oral warfarin History, atrial fibrillation, oral NSAIDS drug history in addition toaspirin, connective tissue disease history, COPD history, HP infection, bleeding sitedifferences without significant (P>0.05), anti-platelet drugs group, were older, more patientswith hypertension, coronary heart disease, cerebral infarction, thrombolysis, smoking history,degree of bleeding, bleeding clinical performance is not the same, bleeding beforegastrointestinal symptoms, history of cancer (P <0.05). Ultimately determine the age, historyof hypertension, history of coronary heart disease, a history of cancer are at high risk ofgastrointestinal bleeding antiplatelet drug-related factors.Conclusions Upper gastrointestinal bleeding the proportion increases every year,antiplatelet drugs may gradually become an important cause of non-variceal uppergastrointestinal bleeding due to a result of taking anti-platelet drugs; gastrointestinal bleedingevents occurred within1year after the oral anti-platelet drugs; Age, history of hypertension,history of coronary heart disease risk factors for anti-platelet drug-related upper gastrointestinal bleeding.